# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-23-039021
Filing Date
2023-05-12
Accepted
2023-05-12 16:10:55
Documents
73
Period of Report
2023-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | QUARTERLY REPORT | f10q0323_jasperthera.htm iXBRL | 10-Q | 718535
2 | CERTIFICATION | f10q0323ex31-1_jasperthera.htm | EX-31.1 | 11040
3 | CERTIFICATION | f10q0323ex31-2_jasperthera.htm | EX-31.2 | 11070
4 | CERTIFICATION | f10q0323ex32-1_jasperthera.htm | EX-32.1 | 6930
| Complete submission text file | 0001213900-23-039021.txt |  | 4805387

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL SCHEMA FILE | jspr-20230331.xsd | EX-101.SCH | 69276
6 | XBRL CALCULATION FILE | jspr-20230331_cal.xml | EX-101.CAL | 37323
7 | XBRL DEFINITION FILE | jspr-20230331_def.xml | EX-101.DEF | 262872
8 | XBRL LABEL FILE | jspr-20230331_lab.xml | EX-101.LAB | 539827
9 | XBRL PRESENTATION FILE | jspr-20230331_pre.xml | EX-101.PRE | 281478
67 | EXTRACTED XBRL INSTANCE DOCUMENT | f10q0323_jasperthera_htm.xml | XML | 463698

Mailing Address 2200 BRIDGE PKWY SUITE #102 REDWOOD CITY CA 94065
Business Address 2200 BRIDGE PKWY SUITE #102 REDWOOD CITY CA 94065 6505491400
Jasper Therapeutics, Inc. (Filer) CIK: 0001788028 (see all company filings)

EIN.: 842984849 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39138 | Film No.: 23915768
SIC: 2836 Biological Products, (No Diagnostic Substances)